Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guerin-unresponsive Carcinoma in Situ of the Bladder. Myers AA, Talwar R, Duan Z, Hensley P, et al. Eur Urol 2026;89:151-162.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Myers AA, Talwar R, Duan Z, Hensley P, et al. Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guerin-unresponsive Carcinoma in Situ of the Bladder. Eur Urol 2026;89:151-162.
PMID: 41046180